Evidence gap analysis
Strategic analysis of the sufficiency of evidence to obtain reimbursement and HTA approval in Europe and recommendations about evidence generation
Recent news and posts
Dutch Healthcare Institute released the “Guideline for conducting health economic evaluations”
On January 16, 2024, the Dutch Healthcare Institute (ZIN) published an updated version of the “Guideline for conducting health economic evaluations”. The objective of this guideline is to set a clear framework for economic evaluations intended for decision-making about the introduction or reimbursement of new healthcare interventions or decision-making about termination of reimbursement for existing healthcare interventions.
The guideline includes the following three modules:
- Cost manual, which focuses on the identification, measurement, and valuation of costs used in economic evaluations;
- QALY and quality-of-life measurements module, which is aimed at measuring health-related quality of life and the various instruments that can be used for this;
- Value of Information analysis module, which focuses on uncertainty, probabilistic analysis, and Value of Information analysis.
The previous version of the Guideline was published in 2016.
See more information in Dutch here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.